March 5, 2011
Nobel laureate J. Michael Bishop, MD, chancellor emeritus of UCSF and professor in the Department of Microbiology and Immunology and director of the G. W. Hooper Foundation, a biomedical research unit at UCSF, will receive Research! America’s 2011 Raymond and Beverly Sackler Award for Sustained National Leadership on March 15.
Research!America is the nation’s largest not-for-profit public education and advocacy alliance working to make research to improve health a higher national priority. The award honors Bishop’s decades of tireless advocacy for medical research as the future of better health and for his efforts to improve the public understanding of science.
Bishop led UCSF for 11 years, steering the health sciences university through one of its most expansive periods of growth and achievement, which included development from the ground up of a second major campus at UCSF Mission Bay, establishment of innovative research programs, and record philanthropic support.
He joined the UCSF faculty in 1968 and in 1981 assumed the additional post as Hooper director. Bishop was named UCSF chancellor in February 1998. Since 2004, he also has held the Arthur and Toni Rembe Rock Distinguished Professorship. While serving as chancellor, Bishop continued to teach medical students and run his distinguished research lab.
In 1989, Bishop was awarded the Nobel Prize in Physiology or Medicine with Harold Varmus, MD, for the discovery that growth regulating genes in normal cells can malfunction and initiate the abnormal growth processes of cancer. Bishop has received numerous prestigious awards in addition to the Nobel Prize, including the Albert Lasker Award for Basic Biomedical Research and the 2003 National Medal of Science.
February 17, 2011
It's unclear how many leading scientists hail from rural Joiner, Arkansas, population 540, but there is at least one: Lewis Lanier, PhD, winner of many scientific honors, including having been named by the Academic Senate as the recipient of the 54th Faculty Research Lectureship in ...
February 15, 2011
The Osher Center for Integrative Medicine at UCSF moved into a new building at the Mount Zion campus.
UCSF's center for integrative medicine has opened the doors of its new home at the UCSF Mount Zion campus. The UCSF Osher Center for Integrative Medicine offers ...
February 4, 2011
The vaccine for human papillomavirus (HPV) can prevent 90 percent of genital warts in men when offered before exposure to the four HPV strains covered by the vaccine, according to a new multi-center study led by H. Lee Moffitt Cancer Center and UCSF.
The four-year, ...
February 4, 2011
Those of us with many birthdays under our belts may look spry on some days and appear haggard on others, but is there any gauge for how well we really are aging within?
Elizabeth Blackburn, PhD, is not ready to predict how long you will ...
January 10, 2011
Cancer is a product of evolution, and understanding how cancer evolves may be a key to more successful treatment strategies.
A billion years ago the world was cancer-free. That’s because Earth was home to only one-celled organisms – bacteria, for instance. Deadly tumors are a ...
December 16, 2010
Brain cancers are deadly more often than not, but UCSF researchers have determined that a particular genetic signature is associated with longer survival.
The discovery, reported online December 15 in the Journal of the National Cancer Institute, may lead to a better understanding of how ...
December 13, 2010
UCSF physicians are combating a devastating side effect of chemotherapy with an innovative new program--"Hair to Stay"--to evaluate devices that could reduce scalp hair loss in breast cancer patients.
One feasibility study on a scalp cooling system, the first significant inquiry of its kind in ...
November 30, 2010
In a new UCSF study of more than 2 million mammogram screenings performed on nearly 700,000 women in the United States, scientists for the first time show a direct link between reduced hormone therapy and declines in ductal carcinoma in situ (DCIS) as well as ...
November 29, 2010
A UCSF research collaboration with GE Healthcare has produced the first results in humans of a new technology that promises to rapidly assess the presence and aggressiveness of prostate tumors in real time, by imaging the tumor's metabolism.
This is the first time researchers have ...